If you are wondering whether MetLife’s current share price reflects its true worth, you are not alone. That is exactly what this valuation focused review aims to unpack.
MetLife recently closed at US$75.32, with returns of 3.7% decline over 7 days, 7.2% decline over 30 days, 6.2% decline year to date and 7.3% decline over 1 year, compared with longer term returns of 16.8% over 3 years and 58.5% over 5 years.
Recent attention around MetLife has centered on its position as a large, established US insurance group and how investors weigh that scale against sector wide concerns such as interest rate trends and capital requirements. For many readers, this context helps frame whether the recent pullback reflects shifting risk perceptions…
